Read More Analyst Ratings News Price Target Credit Suisse Maintains Outperform on Lyft, Lowers Price Target to $69 By Benzinga Newsdesk November 1, 9:32 AM Credit Suisse analyst Stephen Ju maintains Lyft (NASDAQ:LYFT) with a Outperform and lowers the price target from $84 to $69. LYFT
Read More Analyst Ratings News Price Target Keybanc Maintains Overweight on Talos Energy, Raises Price Target to $21 By Benzinga Newsdesk April 8, 4:53 AM Keybanc maintains Talos Energy (NYSE:TALO) with a Overweight and raises the price target from $19 to $21. TALO
Read More Analyst Ratings Downgrades News Price Target Roth Capital Downgrades Workhorse Gr to Neutral, Lowers Price Target to $3.5 By Benzinga Newsdesk August 10, 7:56 AM Roth Capital analyst Craig Irwin downgrades Workhorse Gr (NASDAQ:WKHS) from Buy to Neutral and lowers the price target from $7 to $3.5. WKHS
Read More Biotech Earnings FDA News Previews Top Stories Trading Ideas The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings By Shanthi Rexaline January 20, 3:04 PM Biotech news flow remained light last week, although there were some notable developments such as FDA panel reviews… ABT